1-9 of 9
Michael J. Birrer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Neutralization of TGFβ Improves Tumor Immunity and Reduces Tumor Progression in Ovarian Carcinoma

Available to Purchase
Brandon M. Roane, Selene Meza-Perez, Ashwini A. Katre, Whitney N. Goldsberry, Troy D. Randall, Lyse A. Norian, Michael J. Birrer, Rebecca C. Arend
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (3): 602–611.
https://doi.org/10.1158/1535-7163.MCT-20-0412
Published: 02 March 2021
View articletitled, Neutralization of TGFβ Improves Tumor Immunity and Reduces Tumor Progression in Ovarian Carcinoma
Open the PDF for Neutralization of TGFβ Improves Tumor Immunity and Reduces Tumor Progression in Ovarian Carcinoma in another window
Journal Articles

Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology—Gynecologic Oncology Group Study 240 (NCT 00803062)

Available to Purchase
Krishnansu S. Tewari, Michael W. Sill, Bradley J. Monk, Richard T. Penson, David H. Moore, Heather A. Lankes, Lois M. Ramondetta, Lisa M. Landrum, Leslie M. Randall, Ana Oaknin, Mario M. Leitao, Eric L. Eisenhauer, Paul DiSilvestro, Linda Van Le, Michael L. Pearl, James J. Burke, Ritu Salani, Debra L. Richardson, Helen E. Michael, David W. Kindelberger, Michael J. Birrer
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (11): 2363–2370.
https://doi.org/10.1158/1535-7163.MCT-20-0276
Published: 03 November 2020
View articletitled, Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology—Gynecologic Oncology Group Study 240 (NCT 00803062)
Open the PDF for Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology—Gynecologic Oncology Group Study 240 (NCT 00803062) in another window
Includes: Supplementary data
Journal Articles

Targeting the Nuclear Import Receptor Kpnβ1 as an Anticancer Therapeutic

Free
Pauline J. van der Watt, Alicia Chi, Tamara Stelma, Catherine Stowell, Erin Strydom, Sarah Carden, Liselotte Angus, Kate Hadley, Dirk Lang, Wei Wei, Michael J. Birrer, John O. Trent, Virna D. Leaner
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (4): 560–573.
https://doi.org/10.1158/1535-7163.MCT-15-0052
Published: 05 April 2016
View articletitled, Targeting the Nuclear Import Receptor Kpnβ1 as an Anticancer Therapeutic
Open the PDF for Targeting the Nuclear Import Receptor Kpnβ1 as an Anticancer Therapeutic in another window
Includes: Supplementary data
Journal Articles

Abstract PR05: An assessment of the prognostic and predictive associations of 13 angiogenic biomarkers in women with newly diagnosed advanced ovarian cancer treated with chemotherapy with or without bevacizumab

Free
Wei Wei, Mark F. Brady, Tsun-Yee Tsang, Vinod Vathipadiekal, Robert A. Burger, Robert S. Mannel, Parviz Hanjani, Warner K. Huh, Elizabeth M. Swisher, Thomas J. Rutherford, Janos L. Tanyi, Julian C. Schink, Shashikant B. Lele, Paul A. DiSilvestro, Michael J. Birrer
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_1): PR05.
https://doi.org/10.1158/1538-8514.TUMANG15-PR05
Published: 01 December 2015
View articletitled, Abstract PR05: An assessment of the prognostic and predictive associations of 13 angiogenic biomarkers in women with newly diagnosed advanced ovarian cancer treated with chemotherapy with or without bevacizumab
Journal Articles

Abstract A06: Integration of synthetic lethality and genomic data to identify significant molecular vulnerabilities in ovarian cancer

Free
Geetika Sethi, Harsh Pathak, Hong Zhang, Yan Zhou, Margaret B. Einarson, Vinod Vathipadiekal, Sumedha Gunewardena, Michael J. Birrer, Andrew K. Godwin
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (5_Supplement): A06.
https://doi.org/10.1158/1535-7163.PMS-A06
Published: 01 May 2014
View articletitled, Abstract A06: Integration of synthetic lethality and genomic data to identify significant molecular vulnerabilities in ovarian cancer
Journal Articles

Abstract C234: Decreasing ovarian tumor stromal signaling via SFRP2 mitigates ovarian cancer progression.

Free
Melissa S. Thompson, Lina Albitar, Kwong K. Wong, Tarrik M. Zaid, Michael J. Birrer, Samuel C. Mok
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): C234.
https://doi.org/10.1158/1535-7163.TARG-11-C234
Published: 12 November 2011
View articletitled, Abstract C234: Decreasing ovarian tumor stromal signaling via SFRP2 mitigates ovarian cancer progression.
Journal Articles

Abstract C158: IKKβ inhibition modulates NF‐κB signaling and decreases aggressiveness of ovarian cancer

Free
Lidia Hernandez, Sarah Hsu, Ben Davidson, Michael J. Birrer, Elise C. Kohn, Christina M. Annunziata
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C158.
https://doi.org/10.1158/1535-7163.TARG-09-C158
Published: 10 December 2009
View articletitled, Abstract C158: IKKβ inhibition modulates NF‐κB signaling and decreases aggressiveness of ovarian cancer
Journal Articles

Asparagine synthetase is a predictive biomarker of l-asparaginase activity in ovarian cancer cell lines

Free
Philip L. Lorenzi, Jenny Llamas, Michele Gunsior, Laurent Ozbun, William C. Reinhold, Sudhir Varma, Helen Ji, Hijoo Kim, Amy A. Hutchinson, Elise C. Kohn, Paul K. Goldsmith, Michael J. Birrer, John N. Weinstein
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (10): 3123–3128.
https://doi.org/10.1158/1535-7163.MCT-08-0589
Published: 13 October 2008
View articletitled, Asparagine synthetase is a predictive biomarker of l-asparaginase activity in ovarian cancer cell lines
Open the PDF for Asparagine synthetase is a predictive biomarker of l-asparaginase activity in ovarian cancer cell lines in another window
Includes: Supplementary data
Journal Articles

Reactive oxygen species mediated apoptosis of esophageal cancer cells induced by marine triprenyl toluquinones and toluhydroquinones

Free
Catherine E. Whibley, Kerry L. McPhail, Robert A. Keyzers, Michelle F. Maritz, Virna D. Leaner, Michael J. Birrer, Michael T. Davies-Coleman, Denver T. Hendricks
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (9): 2535–2543.
https://doi.org/10.1158/1535-7163.MCT-06-0760
Published: 17 September 2007
View articletitled, Reactive oxygen species mediated apoptosis of esophageal cancer cells induced by marine triprenyl toluquinones and toluhydroquinones
Open the PDF for Reactive oxygen species mediated apoptosis of esophageal cancer cells induced by marine triprenyl toluquinones and toluhydroquinones in another window